Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fondaparinux sodium does not cross the placental barrier: study using the in-vitro human dually perfused cotyledon model.

× No keyword cloud information.

16 in total

1. Placental transfer of SR49059 in the human dually perfused cotyledon in vitro.

Authors: F J Lagrange; J L Brun; P F Clot; J J Leng; M C Saux; G Kieffer; B G Bannwarth
Journal: Placenta Date: 2001-11 Impact factor: 3.481

2. Effects of pH on antipyrine transfer across the human placenta ex vivo.

Authors: M Giroux; G Campistron; F Faure; J C Dumas; Y Coulais; R Desprats; H Grandjean; G Houin; G Pontonnier
Journal: Dev Pharmacol Ther Date: 1990

3. Transfer across the perfused human placenta of antipyrine, sodium and leucine.

Authors: H Schneider; M Panigel; J Dancis
Journal: Am J Obstet Gynecol Date: 1972-11-15 Impact factor: 8.661

4. Absence of placental transfer of pentasaccharide (Fondaparinux, Arixtra) in the dually perfused human cotyledon in vitro.

Authors: F Lagrange; C Vergnes; J L Brun; F Paolucci; T Nadal; J J Leng; M C Saux; B Banwarth
Journal: Thromb Haemost Date: 2002-05 Impact factor: 5.249

5. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.

Authors: K A Bauer; B I Eriksson; M R Lassen; A G Turpie
Journal: N Engl J Med Date: 2001-11-01 Impact factor: 91.245

6. Fondaparinux sodium mechanism of action: identification of specific binding to purified and human plasma-derived proteins.

Authors: Francis Paolucci; Marie-Christine Claviés; François Donat; José Necciari
Journal: Clin Pharmacokinet Date: 2002 Impact factor: 6.447

7. A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement.

Authors: A G Turpie; A S Gallus; J A Hoek
Journal: N Engl J Med Date: 2001-03-01 Impact factor: 91.245

8. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial.

Authors: Alexander G G Turpie; Kenneth A Bauer; Bengt I Eriksson; Michael R Lassen
Journal: Lancet Date: 2002-05-18 Impact factor: 79.321

9. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison.

Authors: Michael Rud Lassen; Kenneth A Bauer; Bengt I Eriksson; Alexander G G Turpie
Journal: Lancet Date: 2002-05-18 Impact factor: 79.321

10. Passage of S-(+)- and R-(-)-ketoprofen across the human isolated perfused placenta.

Authors: F Lagrange; F Pehourcq; B Bannwarth; J J Leng; M C Saux
Journal: Fundam Clin Pharmacol Date: 1998 Impact factor: 2.748

3 in total

1. The critically ill obstetric patient - Recent concepts.

Authors: Anjan Trikha; Pm Singh
Journal: Indian J Anaesth Date: 2010-09

2. Use of fondaparinux in a pregnant woman with pulmonary embolism and heparin-induced thrombocytopenia.

Authors: Michał Ciurzyński; Krzysztof Jankowski; Bronisława Pietrzak; Natalia Mazanowska; Ewa Rzewuska; Robert Kowalik; Piotr Pruszczyk
Journal: Med Sci Monit Date: 2011-05

3. Fondaparinux Pre-, Peri-, and/or Postpartum for the Prophylaxis/Treatment of Venous Thromboembolism (FondaPPP).

Authors: Carl-Erik Dempfle; Jürgen Koscielny; Edelgard Lindhoff-Last; Birgit Linnemann; Irene Bux-Gewehr; Günther Kappert; Ute Scholz; Stefan Kropff; Sonja Eberle; Peter Bramlage; Andreas Heinken
Journal: Clin Appl Thromb Hemost Date: 2021 Jan-Dec Impact factor: 2.389

3 in total